Oblique Therapeutics Secures SEK 14.1 Million Through Successful Rights Issue#Sweden#Gothenburg#Oblique_Therapeutics#AbiProt#Christer_Nordstedt
Oblique Therapeutics Secures SEK 14.1 Million Through Successful Rights Issue
Oblique Therapeutics AB has successfully completed a rights issue, generating SEK 14.1 million. This funding is critical for advancing their projects and technology platform, AbiProt.
third-news.com
June 30, 2026 at 8:44 AM
Oblique Therapeutics Secures SEK 14.1 Million Through Successful Rights Issue#Sweden#Gothenburg#Oblique_Therapeutics#AbiProt#Christer_Nordstedt